Caroline Hastings

Clinical trials

• Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C

  Principal investigator · Unknown · Phase 1

  Cyclo Therapeutics, Inc.

  2019–2022
• Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

  Principal investigator · Completed · Phase 1

  Cyclo Therapeutics, Inc.

  2017–2020
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes

  Study chair · Completed

  Children's Oncology Group

  2004
• A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

  Site PI · Recruiting · Phase 3

  Azafaros B.V.

  2025–2028